Related Experiment Videos

Role of infections in atherosclerosis

V V Valtonen1

  • 1Division of Infectious Diseases, Department of Medicine, Helsinki, Finland.

American Heart Journal
|October 28, 1999
PubMed

Insights

Infections, including bacteremic and chronic types like Chlamydia pneumoniae, are increasingly recognized as significant risk factors for atherosclerotic diseases such as heart attack and stroke.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Pathogenesis of Atherosclerosis

Background:

  • Epidemiologic, experimental, and clinical studies increasingly link infections to atherosclerotic diseases.
  • Bacteremic infections, with or without endocarditis, elevate the risk of stroke and myocardial infarction.
  • Chronic infections, including Chlamydia pneumoniae and dental infections, are implicated in atherosclerotic disease development.

Purpose of the Study:

  • To review the evidence linking infections to atherosclerotic diseases.
  • To explore the potential role of infections in the etiopathogenesis of atherosclerosis.
  • To discuss the complex and multifactorial mechanisms underlying the infection-atherosclerosis association.

Main Methods:

  • Review of existing epidemiologic, experimental, and clinical evidence.
  • Analysis of the association between various types of infections and atherosclerotic outcomes.
  • Discussion of proposed pathogenetic mechanisms.

Main Results:

  • Infections are established risk factors for acute myocardial infarction and cerebral infarction.
  • Chronic bacterial infections may contribute to the atherosclerotic process itself.
  • Mechanisms linking infection and atherosclerosis are complex, multifactorial, and patient-specific.

Conclusions:

  • Infection is a significant risk factor for atherosclerotic diseases, acting both independently and synergistically with traditional risk factors.
  • The role of infection in atherosclerosis is complex and warrants further investigation.
  • Understanding these mechanisms is crucial for developing novel prevention and treatment strategies for cardiovascular events.

Related Concept Videos